Table 1. Demographic and clinical data in clinical study cohort-1 and cohort-2.

	Healthy controls (n = 38)	Study cohort-1 (n = 38)	Study cohort-2 (n = 13)
Gender (male : female)	30: 8	30: 8	9: 4
Age (yr)†	52.6 (40–69)	53.5 (40–64)	53.0 (43–63)
HBV positive	—	31 (81.6%)	10 (76.9%)
Primary disease (HCC: others)	—	26: 12	12: 1
Median ALT before LTx (U/L)*	22.5 ± 1.2	44.5 ± 380.9	66.9 ± 50.1
Median AST before LTx (U/L)*	19.2 ± 1.7	66.5 ± 257.9	50.2 ± 43.9
Median AFP before LTx (ng/mL)†	—	10.0 (1–6040)	116.2 (2.8–8232)

Abbreviations: HBV, hepatitis B virus; HCC, hepatocellular carcinoma; AFP, alpha-fetoprotein; LTx, liver transplantation.

^†Data are expressed as medians (range).

^*Data are expressed as mean ± S.D. −, not available.